Literature DB >> 22254733

A computerized perimeter for assessing modality-specific visual field loss.

Finnegan J Calabro1, Lucia M Vaina.   

Abstract

The characterization of visual field loss provides a valuable diagnostic metric for studying the effects of damage to the retina, optic nerve or visual cortex. We describe a tool, the Quadrant Vision Perimeter (QVp), to rapidly and accurately measure visual fields. In addition to measuring the location of visual deficits, the tool can assess modality-specific field loss (e.g., impaired detection of luminance, motion, depth and color) and severity of the deficit. We present validation and normalization for parameters of visual attributes, as well as exemplar comparisons of visual fields obtained automatically using QVp to standardized perimeters for three stroke patients. Patient visual fields are compared among visual features to assess modality-specific deficits, and over time, to measure fine changes in visual fields, due either to spontaneous recovery or visual degradation.

Entities:  

Mesh:

Year:  2011        PMID: 22254733      PMCID: PMC3743417          DOI: 10.1109/IEMBS.2011.6090372

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  13 in total

1.  Fundamentals of exact perimetry. 1945.

Authors:  H Goldmann
Journal:  Optom Vis Sci       Date:  1999-08       Impact factor: 1.973

2.  Disappointing results from Nova Vision's visual restoration therapy.

Authors:  J C Horton
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

3.  Programs for diagnosis and therapy of visual field deficits in vision rehabilitation.

Authors:  E Kasten; H Strasburger; B A Sabel
Journal:  Spat Vis       Date:  1997

4.  Restoration of vision II: residual functions and training-induced visual field enlargement in brain-damaged patients.

Authors:  E Kasten; D A Poggel; E Müller-Oehring; J Gothe; T Schulte; B A Sabel
Journal:  Restor Neurol Neurosci       Date:  1999       Impact factor: 2.406

5.  A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter.

Authors:  R W Beck; T J Bergstrom; P R Lichter
Journal:  Ophthalmology       Date:  1985-01       Impact factor: 12.079

6.  Computer-based training for the treatment of partial blindness.

Authors:  E Kasten; S Wüst; W Behrens-Baumann; B A Sabel
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

7.  A comparison of tangent screen, goldmann, and humphrey perimetry in the detection and localization of occipital lesions.

Authors:  A M Wong; J A Sharpe
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

Review 8.  Restoration of vision by training of residual functions.

Authors:  B A Sabel; E Kasten
Journal:  Curr Opin Ophthalmol       Date:  2000-12       Impact factor: 3.761

9.  A comparison of Goldmann and Humphrey automated perimetry in patients with glaucoma.

Authors:  G E Trope; R Britton
Journal:  Br J Ophthalmol       Date:  1987-07       Impact factor: 4.638

10.  Functional and anatomical profile of visual motion impairments in stroke patients correlate with fMRI in normal subjects.

Authors:  Lucia M Vaina; Elif M Sikoglu; Sergei Soloviev; Marjorie LeMay; Salvatore Squatrito; Gabriella Pandiani; Alan Cowey
Journal:  J Neuropsychol       Date:  2009-10-08       Impact factor: 2.864

View more
  2 in total

1.  Neural activity underlying the detection of an object movement by an observer during forward self-motion: Dynamic decoding and temporal evolution of directional cortical connectivity.

Authors:  N Kozhemiako; A S Nunes; A Samal; K D Rana; F J Calabro; M S Hämäläinen; S Khan; L M Vaina
Journal:  Prog Neurobiol       Date:  2020-05-22       Impact factor: 11.685

2.  Spared ability to perceive direction of locomotor heading and scene-relative object movement despite inability to perceive relative motion.

Authors:  Lucia Maria Vaina; Ferdinando Buonanno; Simon K Rushton
Journal:  Med Sci Monit       Date:  2014-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.